Cost-effectiveness and resource allocation (CERA) 18 years of evolution: maturity of adulthood and promise beyond tomorrow

Abstract

Since its inception in 2003, Cost Effectiveness and Resource Allocation journal has come a long way over the past 18 years. Possibly much longer than many of its contemporaries in the blossoming science of health economics might have anticipated. Today, entering 2020 it celebrates the Age of Maturity. We believe that in the third decade of XXI century the interdisciplinary science of health economics, will rejuvenate and come back to us younger than ever from its early historical roots almost a century ago. The spreading of economic globalization in several distinctive ways, either led by multinational business corporations or newly emerged Asian leadership, or both, is likely to make challenges for contemporary health systems far more serious. The fourth industrial revolution (cyber physical systems and artificial intelligence technology) and accelerated innovation in the field of E-Health and digital health, will probably change the workflow in medical and health care, and inevitably transform the labour market in the upcoming decades. So, let us be up to the task. Let us provide academic centres, industry-sponsored pharmaceutical and medical device innovation hubs, and governing authorities alike, with a powerful forum for debate on cost-effective resource allocation in the years to come.

Longevity and Economic Growth in China and India Using a Newly Developed Bootstrap ARDL Model

“…Results show a unidirectional negative Granger causality related with both economic growth and longevity just as longevity and alcohol consumption are also negatively related in China. These results are consistent with Vaupel ( 59 ), Ruhm ( 12 , 13 ), Economou et al ( 15 ), Granados ( 16 ), Cutler et al ( 34 ), Van den Berg ( 17 ), Jakovljevic et al ( 60 ), and Jakovljevic et al ( 61 ) who emphasize a counter-cyclical relationship between economic growth and longevity in China. As incomes increase, so does traffic and business activity, such as alcohol and saturated fat consumption, decreasing immunity levels, directly raising injury-related mortality and decreasing longevity.…”

Real GDP growth rates and healthcare spending – comparison between the G7 and the EM7 countries

“…The increasing influence of the large emerging markets on the global economy has become an important issue that calls for more research and policy attention [21]. This growth is expected to be primarily driven by the emerging markets and developing nations, with the EM7 economies growing at an annual average rate of almost 3.5% during the next 34 years [22]. In contrast, an annual average growth rate of 1.6% is predicted for the G7 countries [23].…”

Organizational measures aiming to combat COVID-19 in the Russian Federation: the first experience

“…Therefore, its average physician density and numbers of hospital beds per 100,000 population remained for decades much higher in comparison to high-income OECD nations such as Japan [31]. Although this system generated financial losses and was not market-oriented, it created a sharp edge of capability for institutional response of a scale [32].…”